G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 1 057.2 INR 2.9% Market Closed
Market Cap: 129.5B INR
Have any thoughts about
Glenmark Life Sciences Ltd?
Write Note

Glenmark Life Sciences Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Glenmark Life Sciences Ltd
Other Long-Term Assets Peer Comparison

Comparables:
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
M
MANKIND

Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
G
Glenmark Life Sciences Ltd
NSE:GLS
Other Long-Term Assets
â‚ą12.7m
CAGR 3-Years
-2%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Other Long-Term Assets
â‚ą8.9B
CAGR 3-Years
-2%
CAGR 5-Years
5%
CAGR 10-Years
23%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Other Long-Term Assets
â‚ą46.2B
CAGR 3-Years
4%
CAGR 5-Years
9%
CAGR 10-Years
15%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Other Long-Term Assets
â‚ą18.4B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Other Long-Term Assets
â‚ą5.7B
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
16%
M
Mankind Pharma Ltd
NSE:MANKIND
Other Long-Term Assets
â‚ą1.1B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Glenmark Life Sciences Ltd's Other Long-Term Assets?
Other Long-Term Assets
12.7m INR

Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Other Long-Term Assets amounts to 12.7m INR.

What is Glenmark Life Sciences Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
-31%

Over the last year, the Other Long-Term Assets growth was 0%. The average annual Other Long-Term Assets growth rates for Glenmark Life Sciences Ltd have been -2% over the past three years , -31% over the past five years .

Back to Top